explore -WSS

explore

author：explore 2025-09-28 01:30:51 - browse：287

James Comer (R-KY) walks on the House side of the U.S. Capitol on May 14, 2024 in Washington, DC — Rep. James Comer (R-Ky.), the chair of the House Committee on Oversight and Accountability, has taken an interest in pharmacy benefit managers. Kent Nishimura/Getty Images

WASHINGTON — Executives from the three major pharmacy benefit manager companies have been invited to testify before the House Committee on Oversight and Accountability next month, four sources familiar with the planning told STAT.

Executives from Optum, CVS Caremark, and Express Scripts, owned by Cigna, were asked to testify before the panel on June 4.

The committee and companies did not respond to requests for comment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： How to improve immunocompromised access to mAb treatments

focus

WSS

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Study: Adult vaccinations pay for themselves in societal benefits

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Senate panel passes drug pricing bills, but drops one PBM reform

Novo pauses ads for weight loss drug Wegovy amid demand

explore

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

Xenotransplantation trials will require adjusting expectations, experts say

Trump demands the U.S. pay no more for drugs than other countries … again

Google says AlphaFold 3 can map a vast universe of biomolecules

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Google says AlphaFold 3 can map a vast universe of biomolecules

Apple is now the first public company to be valued at $3 trillion

After gene therapy, two congenitally deaf children hear for the first time

How one medical school became remarkably diverse

Living organ donors deserve priority status for transplants

knowledge

Mom launches Girl Scout troop for LGBTQ youth in Texas

The thinking behind the controversial eating disorder chatbot Tessa

Biden administration plans revamp of organ transplant system

Bispecific antibodies are next new thing in cancer immunotherapy

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

focus

entertainment

explore

Wikipedia